| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO &COO | CFO And COO +1 more
3 companies
Connealy Pamela Ann is a CFO &COO at Pyxis Oncology, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | PYXS Pyxis Oncology, Inc. | CFO &COO | Buy | 88,850 | $1.96 | $174,364.00 | +4.0% | -31.6% | +198.3% | |
| Sep 28, 2023 | PYXS Pyxis Oncology, Inc. | CFO And COO | Buy | 8,000 | $1.87 | $14,960.00 | +1.0% | -14.7% | +77.5% | |
| Sep 27, 2023 | PYXS Pyxis Oncology, Inc. | CFO And COO | Buy | 6,426 | $1.85 | $11,867.54 | +0.8% | -5.4% | +102.2% | |
| Sep 25, 2023 | PYXS Pyxis Oncology, Inc. | CFO And COO | Buy | 12,000 | $1.67 | $20,043.60 | +1.5% | -2.2% | +102.2% | |
| Sep 22, 2023 | PYXS Pyxis Oncology, Inc. | CFO And COO | Buy | 5,000 | $1.74 | $8,695.00 | +0.6% | +4.4% | +130.6% |